Free Trial
NASDAQ:AEZS

Aeterna Zentaris (AEZS) Stock Price, News & Analysis

Aeterna Zentaris logo
$3.53 +0.02 (+0.57%)
As of 07/11/2025

About Aeterna Zentaris Stock (NASDAQ:AEZS)

Key Stats

Today's Range
$3.31
$3.53
50-Day Range
$3.30
$3.90
52-Week Range
$3.96
$12.00
Volume
3,195 shs
Average Volume
7,305 shs
Market Capitalization
$6.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AEZS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeterna Zentaris and its competitors with MarketBeat's FREE daily newsletter.

AEZS Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
CSCI:CA COSCIENS Biopharma Inc.
Chimerix Inc (CXF.BE)
See More Headlines

AEZS Stock Analysis - Frequently Asked Questions

Aeterna Zentaris' stock was trading at $2.77 at the beginning of 2025. Since then, AEZS stock has increased by 27.4% and is now trading at $3.53.

Aeterna Zentaris Inc. (NASDAQ:AEZS) issued its quarterly earnings data on Thursday, November, 4th. The biopharmaceutical company reported ($1.00) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.00) by $1.00. The biopharmaceutical company had revenue of $0.60 million for the quarter, compared to analysts' expectations of $0.60 million. Aeterna Zentaris had a negative trailing twelve-month return on equity of 83.45% and a negative net margin of 760.32%.

Aeterna Zentaris's stock reverse split on Friday, May 3rd 2024.The 1-4 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Shares of AEZS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aeterna Zentaris investors own include Tonix Pharmaceuticals (TNXP), Bausch Health Cos (BHC), Ford Motor (F), DarioHealth (DRIO), Acasti Pharma (ACST), Onconova Therapeutics (ONTX) and Meta Platforms (META).

Company Calendar

Last Earnings
11/04/2021
Today
7/14/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AEZS
CIK
1113423
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($14.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.55 million
Net Margins
-760.32%
Pretax Margin
-760.28%
Return on Equity
-83.45%
Return on Assets
-45.76%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.94
Quick Ratio
5.93

Sales & Book Value

Annual Sales
$2.37 million
Price / Sales
2.67
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$14.99 per share
Price / Book
0.24

Miscellaneous

Outstanding Shares
1,793,000
Free Float
1,791,000
Market Cap
$6.33 million
Optionable
No Data
Beta
1.55

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:AEZS) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners